Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

By J. Rex, T. Walsh, J. Sobel, S. Filler, P. Pappas, W. Dismukes, J. Edwards. Clinical Infectious Diseases, 2000

946 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/8e04298388ed53e59e0b5983287c8d58c245532c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. T. Walsh
2. M. Ghannoum

In Infectious Diseases

1. J. Nosanchuk
2. D. Trofa
3. A. Gácser
4. Henry F. Chambers
5. M. Ghannoum

Citations in the corpus

• Practice guidelines for the diagnosis and management of skin and soft-tissue infections. (2005, background): “The frequency and occurrence of candidiasis has been well described [183, 184].”
• The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. (2005, background): “comial bloodstream infection in the United States [1, 2]. Candidemia is frequently associated with the signs and symptoms of sepsis syndrome [ 3 , 4]. A recent study of the epidemiology of sepsis revealed that the annual number of cases of sepsis caused by fungal organisms increased by 207% between ”
• Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins (2002, background): “Antifungal therapy alone is insufficient for cure; affected devices generally need to be removed (34, 36, 37, 47).”
• Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. (2013, background): “Antifungal therapy alone is insufficient for curing these infections, and affected devices generally need to be removed (Nucci et al., 1998; Rex et al., 2000).”
• Guidelines for the Management of Intravascular Catheter-Related Infections (2001, background): “Management of infections caused by C albicans and other fungi is summarized in Tables 4-7, Figures 2-4, and the recent IDSA guidelines for the management of candidiasis.(96)”
• Candida parapsilosis, an Emerging Fungal Pathogen (2008, background): “parapsilosis usually require removal for fungal clearance, although some single-case studies report successful treatment of biofilm-associated infections with antifungal therapy alone (146, 176, 190, 228).”
• A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. (2003, background): “Therapeutic guidelines for the management of candidemia have been recently formulated on the basis of results of these trials [ 31 ].”
• Candida Infections of Medical Devices (2004, neutral): “Recently published guidelines by the Infectious Disease Society of America recommended treatment of both complicated and uncomplicated Candida infections of tunneled and nontunneled CVCs by catheter removal in addition to systemic antifungal therapy, generally for 14 days after the last positive blo”
• Guidelines for the management of intravascular catheter-related infections. (2001, background): “albicans and other fungi is summarized in tables 4–7, figures 2–4, and the recent IDSA guidelines for the management of candidiasis [96].”